Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Work from home jobs offer flexibility and extra cash to help pay off debt. Explore opportunities that fit your schedule.
25,050 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
February can test nerves, but smart stock selection pays off. Here are two robust candidates that align with the curr...
A growth stock down dip can open the door to meaningful long-term gains. Learn how to assess, plan, and act with conf...
IBM is shifting to a software-led model with accelerating cash flow and a higher dividend, signaling a durable, AI-ti...
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
A downtown Pittsburgh convenience store is at the center of allegations that SNAP benefits were converted to cash and...
McDonald’s raised its quarterly dividend again as franchisees contend with higher costs and softer consumer demand. T...
Target date funds promise a hands-off path to retirement, but risk shifts as you age. This guide explains how glide p...
Is AppLovin undervalued stock buy? This article breaks down the business, growth outlook, and valuation framework to ...
A shifting geopolitical landscape intersects AI, policy, and crypto. This article breaks down what Anthropic's used I...
When a Veeco director sells a large block, it sparks questions. This article explains what insider trades mean, how t...
A Goldman Sachs note presents a bullish scenario where gold could hit $5,400 per ounce. The outlook reverberates thro...